000 01443 a2200397 4500
005 20250513123317.0
264 0 _c19970919
008 199709s 0 0 jpn d
022 _a0485-1439
040 _aNLM
_beng
_cNLM
100 1 _aNiitsu, N
245 0 0 _a[Prognostic factors of follicular lymphoma treated with combination chemotherapy].
_h[electronic resource]
260 _b[Rinsho ketsueki] The Japanese journal of clinical hematology
_cJun 1997
300 _a496-504 p.
_bdigital
500 _aPublication Type: Clinical Trial; English Abstract; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aBleomycin
_xadministration & dosage
650 0 4 _aCyclophosphamide
_xadministration & dosage
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLymphoma, Follicular
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPrednisolone
_xadministration & dosage
650 0 4 _aPrednisone
_xadministration & dosage
650 0 4 _aProcarbazine
_xadministration & dosage
650 0 4 _aPrognosis
650 0 4 _aSurvival Rate
650 0 4 _aVincristine
_xadministration & dosage
700 1 _aUmeda, M
773 0 _t[Rinsho ketsueki] The Japanese journal of clinical hematology
_gvol. 38
_gno. 6
_gp. 496-504
999 _c9228235
_d9228235